$AVAH
Aveanna Healthcare Holdings, Inc.

2021 Q2 Form 10-Q Financial Statement

#000156459021029784 Filed on May 25, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q1
Revenue $417.2M $355.2M
YoY Change 18.65%
Cost Of Revenue $285.5M
YoY Change
Gross Profit $131.7M $107.5M
YoY Change 23.5%
Gross Profit Margin 31.57% 30.27%
Selling, General & Admin $69.37M $59.69M
YoY Change 25.86%
% of Gross Profit 52.68% 55.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.850M
YoY Change
% of Gross Profit 3.68%
Operating Expenses $69.37M $59.69M
YoY Change 25.86%
Operating Profit $28.30M $17.87M
YoY Change -154.46%
Interest Expense $22.43M $21.06M
YoY Change 19.0%
% of Operating Profit 79.25% 117.89%
Other Income/Expense, Net $159.0K $41.79M
YoY Change -72.91%
Pretax Income $6.107M $38.77M
YoY Change -108.11%
Income Tax $300.0K $1.100M
% Of Pretax Income 4.91% 2.84%
Net Earnings $5.798M $37.64M
YoY Change -107.48%
Net Earnings / Revenue 1.39% 10.6%
Basic Earnings Per Share $0.04 $0.27
Diluted Earnings Per Share $0.04 $0.27
COMMON SHARES
Basic Shares Outstanding 142.1M 137.5M
Diluted Shares Outstanding 146.3M 140.3M

Balance Sheet

Concept 2021 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $67.10M
YoY Change
Cash & Equivalents $67.11M $56.03M
Short-Term Investments
Other Short-Term Assets $9.394M
YoY Change
Inventory
Prepaid Expenses $12.61M
Receivables $195.7M
Other Receivables $0.00
Total Short-Term Assets $293.2M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $32.17M
YoY Change
Goodwill $1.317B
YoY Change
Intangibles $72.27M
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.426M
YoY Change
Total Long-Term Assets $1.505B
YoY Change
TOTAL ASSETS
Total Short-Term Assets $293.2M
Total Long-Term Assets $1.505B
Total Assets $1.798B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $41.90M
YoY Change
Accrued Expenses $63.00M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.800M
YoY Change
Long-Term Debt Due $11.72M
YoY Change
Total Short-Term Liabilities $207.5M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $1.163B
YoY Change
Other Long-Term Liabilities $28.08M
YoY Change
Total Long-Term Liabilities $1.191B
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $207.5M
Total Long-Term Liabilities $1.191B
Total Liabilities $1.524B
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$451.8M
YoY Change
Common Stock $723.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $271.5M $358.1M
YoY Change
Total Liabilities & Shareholders Equity $1.798B
YoY Change

Cashflow Statement

Concept 2021 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $5.798M $37.64M
YoY Change -107.48%
Depreciation, Depletion And Amortization $4.850M
YoY Change
Cash From Operating Activities -$32.91M $44.05M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $2.665M $6.327M
YoY Change
Acquisitions $500.0K
YoY Change
Other Investing Activities -$500.0K
YoY Change
Cash From Investing Activities -$3.165M -$6.327M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $50.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -34.16M 14.98M
YoY Change
NET CHANGE
Cash From Operating Activities -32.91M 44.05M
Cash From Investing Activities -3.165M -6.327M
Cash From Financing Activities -34.16M 14.98M
Net Change In Cash -70.24M 52.71M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$32.91M $44.05M
Capital Expenditures $2.665M $6.327M
Free Cash Flow -$35.58M $37.73M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-01
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001832332
CY2021Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2021Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Entity File Number
EntityFileNumber
001-40362
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
Aveanna Healthcare Holdings Inc.
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-4717209
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
400 Interstate North Parkway SE
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2021Q2 dei City Area Code
CityAreaCode
770
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
441-1580
CY2021Q2 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2021Q2 dei Trading Symbol
TradingSymbol
AVAH
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
184164184
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67105000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137345000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
195720000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
172887000
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12609000
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11080000
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
9394000
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
11340000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
293216000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
340644000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32168000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32650000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
45231000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46217000
CY2021Q2 us-gaap Goodwill
Goodwill
1317340000
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1814000
CY2021Q1 us-gaap Notes Payable Current
NotesPayableCurrent
2872000
CY2021Q2 avah Current Portion Of Insurance Reserves Insured Programs
CurrentPortionOfInsuranceReservesInsuredPrograms
8388000
CY2021Q1 us-gaap Goodwill
Goodwill
1316385000
CY2021Q1 avah Current Portion Of Insurance Reserves Insured Programs
CurrentPortionOfInsuranceReservesInsuredPrograms
7992000
CY2021Q2 avah Current Portion Of Insurance Reserves
CurrentPortionOfInsuranceReserves
13186000
CY2021Q1 avah Current Portion Of Insurance Reserves
CurrentPortionOfInsuranceReserves
12294000
CY2021Q2 us-gaap Loans Payable Current
LoansPayableCurrent
9910000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
72266000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73572000
CY2021Q2 avah Receivables Under Insured Programs Noncurrent
ReceivablesUnderInsuredProgramsNoncurrent
25184000
CY2021Q1 us-gaap Loans Payable Current
LoansPayableCurrent
9910000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11312000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11884000
CY2021Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
24824000
CY2021Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
24824000
CY2021Q1 avah Government Stimulus Liabilities
GovernmentStimulusLiabilities
29444000
CY2021Q1 avah Receivables Under Insured Programs Noncurrent
ReceivablesUnderInsuredProgramsNoncurrent
23990000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
44430000
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45293000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
207485000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
260413000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2931000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2931000
CY2021Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
1163059000
CY2021Q1 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
1163490000
CY2021Q2 avah Long Term Insurance Reserves Insured Programs
LongTermInsuranceReservesInsuredPrograms
25184000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9426000
CY2021Q1 avah Long Term Insurance Reserves Insured Programs
LongTermInsuranceReservesInsuredPrograms
23990000
CY2021Q2 avah Long Term Insurance Reserves
LongTermInsuranceReserves
32910000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7627000
CY2021Q1 avah Long Term Insurance Reserves
LongTermInsuranceReserves
30336000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
39260000
CY2021Q2 us-gaap Assets
Assets
1797762000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
40246000
CY2021Q1 us-gaap Assets
Assets
1844016000
CY2021Q2 avah Deferred Payroll Taxes
DeferredPayrollTaxes
24824000
CY2021Q1 avah Deferred Payroll Taxes
DeferredPayrollTaxes
24824000
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3285000
CY2021Q2 avah Accrued Payroll And Employee Benefits
AccruedPayrollAndEmployeeBenefits
49239000
CY2021Q1 avah Accrued Payroll And Employee Benefits
AccruedPayrollAndEmployeeBenefits
56834000
CY2021Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
56668000
CY2021Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
41906000
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2591000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28076000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
30957000
CY2021Q2 us-gaap Liabilities
Liabilities
1524083000
CY2021Q1 us-gaap Liabilities
Liabilities
1576847000
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2476000
CY2021Q1 us-gaap Interest Payable Current
InterestPayableCurrent
2398000
CY2021Q2 avah Receivables Under Insured Programs Current
ReceivablesUnderInsuredProgramsCurrent
8388000
CY2021Q1 avah Receivables Under Insured Programs Current
ReceivablesUnderInsuredProgramsCurrent
7992000
CY2021Q2 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2135000
CY2021Q1 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2135000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141928184
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141928184
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141928184
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141928184
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1419000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
1419000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
721959000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
721247000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-451834000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-457632000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
271544000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
265034000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1797762000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1844016000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417160000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
355223000
CY2021Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
285477000
CY2020Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
247682000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
69372000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59694000
CY2021Q2 avah Corporate Expenses
CorporateExpenses
27399000
CY2020Q1 avah Corporate Expenses
CorporateExpenses
25797000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4848000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4183000
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1768000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
28296000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17867000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
77000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
46000
CY2021Q2 us-gaap Interest Expense
InterestExpense
22425000
CY2020Q1 us-gaap Interest Expense
InterestExpense
21063000
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
127000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
159000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
41791000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6107000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38768000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1131000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
5798000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
37637000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142122934
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
137468875
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146266014
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140330909
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
265034000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
712000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
5798000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
271544000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
270192000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
318000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
37637000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
358147000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
5798000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
37637000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4848000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4183000
CY2021Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2140000
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1744000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3550000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3123000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
712000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
318000
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
4000
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-48000
CY2021Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2820000
CY2020Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-6422000
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
127000
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
694000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
573000
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22852000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1168000
CY2021Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1684000
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1760000
CY2021Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1957000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2748000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-15841000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10187000
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-7595000
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1881000
CY2021Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
78000
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1826000
CY2021Q2 us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
3466000
CY2020Q1 us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
684000
CY2021Q2 avah Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-4126000
CY2020Q1 avah Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-3317000
CY2020Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-885000
CY2021Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1232000
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1218000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32911000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44053000
CY2021Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
500000
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2665000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6327000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3165000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6327000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000000
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
14000000
CY2020Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
45500000
CY2021Q2 avah Payments On Term Loans And Notes Payable
PaymentsOnTermLoansAndNotesPayable
3535000
CY2020Q1 avah Payments On Term Loans And Notes Payable
PaymentsOnTermLoansAndNotesPayable
2677000
CY2021Q2 avah Payment Of Government Stimulus Funds
PaymentOfGovernmentStimulusFunds
29444000
CY2021Q2 avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
203000
CY2020Q1 avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
153000
CY2021Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
196000
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
689000
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
786000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14981000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34164000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-70240000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
52707000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
137345000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3327000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67105000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56034000
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
20207000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
17493000
CY2021Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2520000
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4003000
CY2021Q2 avah Deferred Offering Costs Included In Accounts Payable And Other Accrued Liabilities
DeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedLiabilities
1874000
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-202000
CY2021Q2 us-gaap Nature Of Operations
NatureOfOperations
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</span></p></td> <td valign="top"> <p id="NOTES_TO_UNAUDITED_CONSOLIDATED_FINANCIA" style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">DESCRIPTION OF BUSINESS </p></td></tr></table></div> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Aveanna Healthcare Holdings Inc. (together with its consolidated subsidiaries, referred to herein as the “Company”) is headquartered in Atlanta, Georgia and has operations in 30 states with concentrations in Texas, Pennsylvania, and California, providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization</span>.</p>
CY2021Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
30
CY2021Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-style:italic;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s accounting and reporting policies conform with U.S. GAAP. In preparing the consolidated financial statements, the Company is required to make estimates and assumptions that impact the amounts reported in these consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</p>
CY2021Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
4800000
CY2021Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
2900000
CY2021Q2 avah Estimated Price Concession
EstimatedPriceConcession
56300000
CY2021Q1 avah Estimated Price Concession
EstimatedPriceConcession
55400000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417160000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
355223000
CY2021Q2 avah Business Combination Acquisition Related Transaction Costs
BusinessCombinationAcquisitionRelatedTransactionCosts
1800000
CY2020Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1204069000
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1207604000
CY2021Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
29286000
CY2021Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
31332000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
1174783000
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
1176272000
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
11724000
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
12782000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1163059000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1163490000
CY2021Q2 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
L = Greater of 1.00% or one-month LIBOR
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2100000
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1700000
CY2021Q2 avah Swingline Loan
SwinglineLoan
0
CY2021Q1 avah Swingline Loan
SwinglineLoan
0
CY2021Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
25804000
CY2021Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
28624000
CY2021Q2 us-gaap Malpractice Insurance Maximum Coverage Per Incident
MalpracticeInsuranceMaximumCoveragePerIncident
6000000.0
CY2021Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
79700000
CY2021Q2 us-gaap Malpractice Insurance Deductible1
MalpracticeInsuranceDeductible1
500000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.048
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.029
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000000.0
CY2021Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
74600000
CY2020Q1 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
50000000.0
CY2018Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
75000000.0
CY2019Q4 avah Break Up Fee Payable
BreakUpFeePayable
0
CY2021 avah Provider Relief Fund Payments Received Cares Act
ProviderReliefFundPaymentsReceivedCARESAct
25100000
CY2021Q2 avah Incremental Percentage Of Deferred Payment Of Employer Portion Of Social Security Taxes
IncrementalPercentageOfDeferredPaymentOfEmployerPortionOfSocialSecurityTaxes
0.50
CY2021Q2 avah Deferred Social Security Tax Cares Act
DeferredSocialSecurityTaxCARESAct
49600000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59694000
CY2021Q2 us-gaap Gross Profit
GrossProfit
131683000
CY2021Q2 avah Gross Margin Percentage
GrossMarginPercentage
0.316
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
355223000
CY2020Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
247682000
CY2020Q1 us-gaap Gross Profit
GrossProfit
107541000
CY2020Q1 avah Gross Margin Percentage
GrossMarginPercentage
0.303
CY2021Q2 us-gaap Gross Profit
GrossProfit
131683000
CY2020Q1 us-gaap Gross Profit
GrossProfit
107541000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
69372000
CY2021Q2 us-gaap Management Fee Expense
ManagementFeeExpense
900000
CY2020Q1 us-gaap Management Fee Expense
ManagementFeeExpense
800000
CY2021Q2 avah Advisory Services Expense Outstanding
AdvisoryServicesExpenseOutstanding
0
CY2021Q1 avah Advisory Services Expense Outstanding
AdvisoryServicesExpenseOutstanding
1600000
CY2021Q2 avah Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services
OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServices
100000
CY2020Q1 avah Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services
OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServices
100000
CY2021Q2 avah Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services Outstanding
OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServicesOutstanding
0
CY2021Q1 avah Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services Outstanding
OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServicesOutstanding
0
CY2021Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2021Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
417160000
CY2021Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
285477000
CY2021Q2 avah Corporate Expenses
CorporateExpenses
27399000
CY2020Q1 avah Corporate Expenses
CorporateExpenses
25797000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4848000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4183000
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1768000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
28296000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17867000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
77000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
46000
CY2021Q2 us-gaap Interest Expense
InterestExpense
22425000
CY2020Q1 us-gaap Interest Expense
InterestExpense
21063000
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
127000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
159000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
41791000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6107000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38768000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
5798000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
137468875
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
37637000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142122934
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146266014
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140330909
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27

Files In Submission

Name View Source Status
0001564590-21-029784-index-headers.html Edgar Link pending
0001564590-21-029784-index.html Edgar Link pending
0001564590-21-029784.txt Edgar Link pending
0001564590-21-029784-xbrl.zip Edgar Link pending
avah-10q_20210403.htm Edgar Link pending
avah-10q_20210403_htm.xml Edgar Link completed
avah-20210403.xsd Edgar Link pending
avah-20210403_cal.xml Edgar Link unprocessable
avah-20210403_def.xml Edgar Link unprocessable
avah-20210403_lab.xml Edgar Link unprocessable
avah-20210403_pre.xml Edgar Link unprocessable
avah-ex311_6.htm Edgar Link pending
avah-ex312_7.htm Edgar Link pending
avah-ex321_8.htm Edgar Link pending
avah-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gnkliliusjz1000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending